Global Endoparasiticide Market Insights, Forecast to 2029
This report presents an overview of global market for Endoparasiticide, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Endoparasiticide, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Endoparasiticide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Endoparasiticide sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Endoparasiticide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Endoparasiticide sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG and Eli Lilly, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Endoparasiticide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Endoparasiticide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endoparasiticide sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Endoparasiticide, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Endoparasiticide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Endoparasiticide sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Endoparasiticide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Endoparasiticide sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG and Eli Lilly, etc.
By Company
- Boehringer Ingelheim
- Elanco
- Zoetis
- Merck
- Virbac
- Novartis AG
- Ceva Sante Animlae
- Bayer AG
- Eli Lilly
- Vetoquinol
- Ear Tags
- Tablets
- Injectables
- Feed Additives
- Veterinary Hospitals or Clinics
- Animal Farms
- Home Care Settings
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Endoparasiticide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Endoparasiticide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endoparasiticide sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Endoparasiticide Product Introduction
1.2 Market by Type
1.2.1 Global Endoparasiticide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Ear Tags
1.2.3 Tablets
1.2.4 Injectables
1.2.5 Feed Additives
1.3 Market by Application
1.3.1 Global Endoparasiticide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Veterinary Hospitals or Clinics
1.3.3 Animal Farms
1.3.4 Home Care Settings
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Endoparasiticide Sales Estimates and Forecasts 2018-2029
2.2 Global Endoparasiticide Revenue by Region
2.2.1 Global Endoparasiticide Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Endoparasiticide Revenue by Region (2018-2023)
2.2.3 Global Endoparasiticide Revenue by Region (2024-2029)
2.2.4 Global Endoparasiticide Revenue Market Share by Region (2018-2029)
2.3 Global Endoparasiticide Sales Estimates and Forecasts 2018-2029
2.4 Global Endoparasiticide Sales by Region
2.4.1 Global Endoparasiticide Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Endoparasiticide Sales by Region (2018-2023)
2.4.3 Global Endoparasiticide Sales by Region (2024-2029)
2.4.4 Global Endoparasiticide Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Endoparasiticide Sales by Manufacturers
3.1.1 Global Endoparasiticide Sales by Manufacturers (2018-2023)
3.1.2 Global Endoparasiticide Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Endoparasiticide in 2022
3.2 Global Endoparasiticide Revenue by Manufacturers
3.2.1 Global Endoparasiticide Revenue by Manufacturers (2018-2023)
3.2.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Endoparasiticide Revenue in 2022
3.3 Global Key Players of Endoparasiticide, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Endoparasiticide Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Endoparasiticide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Endoparasiticide, Product Offered and Application
3.8 Global Key Manufacturers of Endoparasiticide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Endoparasiticide Sales by Type
4.1.1 Global Endoparasiticide Historical Sales by Type (2018-2023)
4.1.2 Global Endoparasiticide Forecasted Sales by Type (2024-2029)
4.1.3 Global Endoparasiticide Sales Market Share by Type (2018-2029)
4.2 Global Endoparasiticide Revenue by Type
4.2.1 Global Endoparasiticide Historical Revenue by Type (2018-2023)
4.2.2 Global Endoparasiticide Forecasted Revenue by Type (2024-2029)
4.2.3 Global Endoparasiticide Revenue Market Share by Type (2018-2029)
4.3 Global Endoparasiticide Price by Type
4.3.1 Global Endoparasiticide Price by Type (2018-2023)
4.3.2 Global Endoparasiticide Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Endoparasiticide Sales by Application
5.1.1 Global Endoparasiticide Historical Sales by Application (2018-2023)
5.1.2 Global Endoparasiticide Forecasted Sales by Application (2024-2029)
5.1.3 Global Endoparasiticide Sales Market Share by Application (2018-2029)
5.2 Global Endoparasiticide Revenue by Application
5.2.1 Global Endoparasiticide Historical Revenue by Application (2018-2023)
5.2.2 Global Endoparasiticide Forecasted Revenue by Application (2024-2029)
5.2.3 Global Endoparasiticide Revenue Market Share by Application (2018-2029)
5.3 Global Endoparasiticide Price by Application
5.3.1 Global Endoparasiticide Price by Application (2018-2023)
5.3.2 Global Endoparasiticide Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Endoparasiticide Market Size by Type
6.1.1 US & Canada Endoparasiticide Sales by Type (2018-2029)
6.1.2 US & Canada Endoparasiticide Revenue by Type (2018-2029)
6.2 US & Canada Endoparasiticide Market Size by Application
6.2.1 US & Canada Endoparasiticide Sales by Application (2018-2029)
6.2.2 US & Canada Endoparasiticide Revenue by Application (2018-2029)
6.3 US & Canada Endoparasiticide Market Size by Country
6.3.1 US & Canada Endoparasiticide Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Endoparasiticide Sales by Country (2018-2029)
6.3.3 US & Canada Endoparasiticide Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Endoparasiticide Market Size by Type
7.1.1 Europe Endoparasiticide Sales by Type (2018-2029)
7.1.2 Europe Endoparasiticide Revenue by Type (2018-2029)
7.2 Europe Endoparasiticide Market Size by Application
7.2.1 Europe Endoparasiticide Sales by Application (2018-2029)
7.2.2 Europe Endoparasiticide Revenue by Application (2018-2029)
7.3 Europe Endoparasiticide Market Size by Country
7.3.1 Europe Endoparasiticide Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Endoparasiticide Sales by Country (2018-2029)
7.3.3 Europe Endoparasiticide Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Endoparasiticide Market Size
8.1.1 China Endoparasiticide Sales (2018-2029)
8.1.2 China Endoparasiticide Revenue (2018-2029)
8.2 China Endoparasiticide Market Size by Application
8.2.1 China Endoparasiticide Sales by Application (2018-2029)
8.2.2 China Endoparasiticide Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Endoparasiticide Market Size by Type
9.1.1 Asia Endoparasiticide Sales by Type (2018-2029)
9.1.2 Asia Endoparasiticide Revenue by Type (2018-2029)
9.2 Asia Endoparasiticide Market Size by Application
9.2.1 Asia Endoparasiticide Sales by Application (2018-2029)
9.2.2 Asia Endoparasiticide Revenue by Application (2018-2029)
9.3 Asia Endoparasiticide Sales by Region
9.3.1 Asia Endoparasiticide Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Endoparasiticide Revenue by Region (2018-2029)
9.3.3 Asia Endoparasiticide Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Endoparasiticide Market Size by Type
10.1.1 Middle East, Africa and Latin America Endoparasiticide Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Endoparasiticide Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Endoparasiticide Market Size by Application
10.2.1 Middle East, Africa and Latin America Endoparasiticide Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Endoparasiticide Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Endoparasiticide Sales by Country
10.3.1 Middle East, Africa and Latin America Endoparasiticide Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Endoparasiticide Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Endoparasiticide Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Boehringer Ingelheim Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Elanco
11.2.1 Elanco Company Information
11.2.2 Elanco Overview
11.2.3 Elanco Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Elanco Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Elanco Recent Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Zoetis Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Overview
11.4.3 Merck Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Merck Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Virbac
11.5.1 Virbac Company Information
11.5.2 Virbac Overview
11.5.3 Virbac Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Virbac Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Virbac Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Novartis AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Ceva Sante Animlae
11.7.1 Ceva Sante Animlae Company Information
11.7.2 Ceva Sante Animlae Overview
11.7.3 Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Ceva Sante Animlae Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Sante Animlae Recent Developments
11.8 Bayer AG
11.8.1 Bayer AG Company Information
11.8.2 Bayer AG Overview
11.8.3 Bayer AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bayer AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bayer AG Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Eli Lilly Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Vetoquinol
11.10.1 Vetoquinol Company Information
11.10.2 Vetoquinol Overview
11.10.3 Vetoquinol Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Vetoquinol Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vetoquinol Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Endoparasiticide Industry Chain Analysis
12.2 Endoparasiticide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Endoparasiticide Production Mode & Process
12.4 Endoparasiticide Sales and Marketing
12.4.1 Endoparasiticide Sales Channels
12.4.2 Endoparasiticide Distributors
12.5 Endoparasiticide Customers
13 MARKET DYNAMICS
13.1 Endoparasiticide Industry Trends
13.2 Endoparasiticide Market Drivers
13.3 Endoparasiticide Market Challenges
13.4 Endoparasiticide Market Restraints
14 KEY FINDINGS IN THE GLOBAL ENDOPARASITICIDE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Endoparasiticide Product Introduction
1.2 Market by Type
1.2.1 Global Endoparasiticide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Ear Tags
1.2.3 Tablets
1.2.4 Injectables
1.2.5 Feed Additives
1.3 Market by Application
1.3.1 Global Endoparasiticide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Veterinary Hospitals or Clinics
1.3.3 Animal Farms
1.3.4 Home Care Settings
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Endoparasiticide Sales Estimates and Forecasts 2018-2029
2.2 Global Endoparasiticide Revenue by Region
2.2.1 Global Endoparasiticide Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Endoparasiticide Revenue by Region (2018-2023)
2.2.3 Global Endoparasiticide Revenue by Region (2024-2029)
2.2.4 Global Endoparasiticide Revenue Market Share by Region (2018-2029)
2.3 Global Endoparasiticide Sales Estimates and Forecasts 2018-2029
2.4 Global Endoparasiticide Sales by Region
2.4.1 Global Endoparasiticide Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Endoparasiticide Sales by Region (2018-2023)
2.4.3 Global Endoparasiticide Sales by Region (2024-2029)
2.4.4 Global Endoparasiticide Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Endoparasiticide Sales by Manufacturers
3.1.1 Global Endoparasiticide Sales by Manufacturers (2018-2023)
3.1.2 Global Endoparasiticide Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Endoparasiticide in 2022
3.2 Global Endoparasiticide Revenue by Manufacturers
3.2.1 Global Endoparasiticide Revenue by Manufacturers (2018-2023)
3.2.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Endoparasiticide Revenue in 2022
3.3 Global Key Players of Endoparasiticide, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Endoparasiticide Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Endoparasiticide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Endoparasiticide, Product Offered and Application
3.8 Global Key Manufacturers of Endoparasiticide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Endoparasiticide Sales by Type
4.1.1 Global Endoparasiticide Historical Sales by Type (2018-2023)
4.1.2 Global Endoparasiticide Forecasted Sales by Type (2024-2029)
4.1.3 Global Endoparasiticide Sales Market Share by Type (2018-2029)
4.2 Global Endoparasiticide Revenue by Type
4.2.1 Global Endoparasiticide Historical Revenue by Type (2018-2023)
4.2.2 Global Endoparasiticide Forecasted Revenue by Type (2024-2029)
4.2.3 Global Endoparasiticide Revenue Market Share by Type (2018-2029)
4.3 Global Endoparasiticide Price by Type
4.3.1 Global Endoparasiticide Price by Type (2018-2023)
4.3.2 Global Endoparasiticide Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Endoparasiticide Sales by Application
5.1.1 Global Endoparasiticide Historical Sales by Application (2018-2023)
5.1.2 Global Endoparasiticide Forecasted Sales by Application (2024-2029)
5.1.3 Global Endoparasiticide Sales Market Share by Application (2018-2029)
5.2 Global Endoparasiticide Revenue by Application
5.2.1 Global Endoparasiticide Historical Revenue by Application (2018-2023)
5.2.2 Global Endoparasiticide Forecasted Revenue by Application (2024-2029)
5.2.3 Global Endoparasiticide Revenue Market Share by Application (2018-2029)
5.3 Global Endoparasiticide Price by Application
5.3.1 Global Endoparasiticide Price by Application (2018-2023)
5.3.2 Global Endoparasiticide Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Endoparasiticide Market Size by Type
6.1.1 US & Canada Endoparasiticide Sales by Type (2018-2029)
6.1.2 US & Canada Endoparasiticide Revenue by Type (2018-2029)
6.2 US & Canada Endoparasiticide Market Size by Application
6.2.1 US & Canada Endoparasiticide Sales by Application (2018-2029)
6.2.2 US & Canada Endoparasiticide Revenue by Application (2018-2029)
6.3 US & Canada Endoparasiticide Market Size by Country
6.3.1 US & Canada Endoparasiticide Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Endoparasiticide Sales by Country (2018-2029)
6.3.3 US & Canada Endoparasiticide Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Endoparasiticide Market Size by Type
7.1.1 Europe Endoparasiticide Sales by Type (2018-2029)
7.1.2 Europe Endoparasiticide Revenue by Type (2018-2029)
7.2 Europe Endoparasiticide Market Size by Application
7.2.1 Europe Endoparasiticide Sales by Application (2018-2029)
7.2.2 Europe Endoparasiticide Revenue by Application (2018-2029)
7.3 Europe Endoparasiticide Market Size by Country
7.3.1 Europe Endoparasiticide Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Endoparasiticide Sales by Country (2018-2029)
7.3.3 Europe Endoparasiticide Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Endoparasiticide Market Size
8.1.1 China Endoparasiticide Sales (2018-2029)
8.1.2 China Endoparasiticide Revenue (2018-2029)
8.2 China Endoparasiticide Market Size by Application
8.2.1 China Endoparasiticide Sales by Application (2018-2029)
8.2.2 China Endoparasiticide Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Endoparasiticide Market Size by Type
9.1.1 Asia Endoparasiticide Sales by Type (2018-2029)
9.1.2 Asia Endoparasiticide Revenue by Type (2018-2029)
9.2 Asia Endoparasiticide Market Size by Application
9.2.1 Asia Endoparasiticide Sales by Application (2018-2029)
9.2.2 Asia Endoparasiticide Revenue by Application (2018-2029)
9.3 Asia Endoparasiticide Sales by Region
9.3.1 Asia Endoparasiticide Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Endoparasiticide Revenue by Region (2018-2029)
9.3.3 Asia Endoparasiticide Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Endoparasiticide Market Size by Type
10.1.1 Middle East, Africa and Latin America Endoparasiticide Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Endoparasiticide Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Endoparasiticide Market Size by Application
10.2.1 Middle East, Africa and Latin America Endoparasiticide Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Endoparasiticide Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Endoparasiticide Sales by Country
10.3.1 Middle East, Africa and Latin America Endoparasiticide Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Endoparasiticide Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Endoparasiticide Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Boehringer Ingelheim Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Elanco
11.2.1 Elanco Company Information
11.2.2 Elanco Overview
11.2.3 Elanco Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Elanco Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Elanco Recent Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Zoetis Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Overview
11.4.3 Merck Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Merck Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Virbac
11.5.1 Virbac Company Information
11.5.2 Virbac Overview
11.5.3 Virbac Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Virbac Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Virbac Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Novartis AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Ceva Sante Animlae
11.7.1 Ceva Sante Animlae Company Information
11.7.2 Ceva Sante Animlae Overview
11.7.3 Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Ceva Sante Animlae Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Sante Animlae Recent Developments
11.8 Bayer AG
11.8.1 Bayer AG Company Information
11.8.2 Bayer AG Overview
11.8.3 Bayer AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bayer AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bayer AG Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Eli Lilly Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Vetoquinol
11.10.1 Vetoquinol Company Information
11.10.2 Vetoquinol Overview
11.10.3 Vetoquinol Endoparasiticide Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Vetoquinol Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vetoquinol Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Endoparasiticide Industry Chain Analysis
12.2 Endoparasiticide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Endoparasiticide Production Mode & Process
12.4 Endoparasiticide Sales and Marketing
12.4.1 Endoparasiticide Sales Channels
12.4.2 Endoparasiticide Distributors
12.5 Endoparasiticide Customers
13 MARKET DYNAMICS
13.1 Endoparasiticide Industry Trends
13.2 Endoparasiticide Market Drivers
13.3 Endoparasiticide Market Challenges
13.4 Endoparasiticide Market Restraints
14 KEY FINDINGS IN THE GLOBAL ENDOPARASITICIDE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Endoparasiticide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Ear Tags
Table 3. Major Manufacturers of Tablets
Table 4. Major Manufacturers of Injectables
Table 5. Major Manufacturers of Feed Additives
Table 6. Global Endoparasiticide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Endoparasiticide Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Endoparasiticide Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Endoparasiticide Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Endoparasiticide Revenue Market Share by Region (2018-2023)
Table 11. Global Endoparasiticide Revenue Market Share by Region (2024-2029)
Table 12. Global Endoparasiticide Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Endoparasiticide Sales by Region (2018-2023) & (K Units)
Table 14. Global Endoparasiticide Sales by Region (2024-2029) & (K Units)
Table 15. Global Endoparasiticide Sales Market Share by Region (2018-2023)
Table 16. Global Endoparasiticide Sales Market Share by Region (2024-2029)
Table 17. Global Endoparasiticide Sales by Manufacturers (2018-2023) & (K Units)
Table 18. Global Endoparasiticide Sales Share by Manufacturers (2018-2023)
Table 19. Global Endoparasiticide Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Endoparasiticide Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Endoparasiticide, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Endoparasiticide Price by Manufacturers 2018-2023 (US$/Unit)
Table 23. Global Endoparasiticide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Endoparasiticide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoparasiticide as of 2022)
Table 25. Global Key Manufacturers of Endoparasiticide, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Endoparasiticide, Product Offered and Application
Table 27. Global Key Manufacturers of Endoparasiticide, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 30. Global Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 31. Global Endoparasiticide Sales Share by Type (2018-2023)
Table 32. Global Endoparasiticide Sales Share by Type (2024-2029)
Table 33. Global Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Endoparasiticide Revenue Share by Type (2018-2023)
Table 36. Global Endoparasiticide Revenue Share by Type (2024-2029)
Table 37. Endoparasiticide Price by Type (2018-2023) & (US$/Unit)
Table 38. Global Endoparasiticide Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 40. Global Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 41. Global Endoparasiticide Sales Share by Application (2018-2023)
Table 42. Global Endoparasiticide Sales Share by Application (2024-2029)
Table 43. Global Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Endoparasiticide Revenue Share by Application (2018-2023)
Table 46. Global Endoparasiticide Revenue Share by Application (2024-2029)
Table 47. Endoparasiticide Price by Application (2018-2023) & (US$/Unit)
Table 48. Global Endoparasiticide Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 50. US & Canada Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 54. US & Canada Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Endoparasiticide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Endoparasiticide Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Endoparasiticide Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Endoparasiticide Sales by Country (2018-2023) & (K Units)
Table 61. US & Canada Endoparasiticide Sales by Country (2024-2029) & (K Units)
Table 62. Europe Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 63. Europe Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 64. Europe Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 67. Europe Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 68. Europe Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Endoparasiticide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Endoparasiticide Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Endoparasiticide Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Endoparasiticide Sales by Country (2018-2023) & (K Units)
Table 74. Europe Endoparasiticide Sales by Country (2024-2029) & (K Units)
Table 75. China Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 76. China Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 77. China Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 80. China Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 81. China Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 84. Asia Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 85. Asia Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 88. Asia Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 89. Asia Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Endoparasiticide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Endoparasiticide Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Endoparasiticide Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Endoparasiticide Sales by Region (2018-2023) & (K Units)
Table 95. Asia Endoparasiticide Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 97. Middle East, Africa and Latin America Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 101. Middle East, Africa and Latin America Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Endoparasiticide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Endoparasiticide Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Endoparasiticide Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Endoparasiticide Sales by Country (2018-2023) & (K Units)
Table 108. Middle East, Africa and Latin America Endoparasiticide Sales by Country (2024-2029) & (K Units)
Table 109. Boehringer Ingelheim Company Information
Table 110. Boehringer Ingelheim Description and Major Businesses
Table 111. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Boehringer Ingelheim Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Boehringer Ingelheim Recent Developments
Table 114. Elanco Company Information
Table 115. Elanco Description and Major Businesses
Table 116. Elanco Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Elanco Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Elanco Recent Developments
Table 119. Zoetis Company Information
Table 120. Zoetis Description and Major Businesses
Table 121. Zoetis Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Zoetis Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Zoetis Recent Developments
Table 124. Merck Company Information
Table 125. Merck Description and Major Businesses
Table 126. Merck Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Merck Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Merck Recent Developments
Table 129. Virbac Company Information
Table 130. Virbac Description and Major Businesses
Table 131. Virbac Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Virbac Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Virbac Recent Developments
Table 134. Novartis AG Company Information
Table 135. Novartis AG Description and Major Businesses
Table 136. Novartis AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Novartis AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Novartis AG Recent Developments
Table 139. Ceva Sante Animlae Company Information
Table 140. Ceva Sante Animlae Description and Major Businesses
Table 141. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Ceva Sante Animlae Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Ceva Sante Animlae Recent Developments
Table 144. Bayer AG Company Information
Table 145. Bayer AG Description and Major Businesses
Table 146. Bayer AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Bayer AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Bayer AG Recent Developments
Table 149. Eli Lilly Company Information
Table 150. Eli Lilly Description and Major Businesses
Table 151. Eli Lilly Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Eli Lilly Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Eli Lilly Recent Developments
Table 154. Vetoquinol Company Information
Table 155. Vetoquinol Description and Major Businesses
Table 156. Vetoquinol Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Vetoquinol Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Vetoquinol Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Endoparasiticide Distributors List
Table 162. Endoparasiticide Customers List
Table 163. Endoparasiticide Market Trends
Table 164. Endoparasiticide Market Drivers
Table 165. Endoparasiticide Market Challenges
Table 166. Endoparasiticide Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
Table 1. Global Endoparasiticide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Ear Tags
Table 3. Major Manufacturers of Tablets
Table 4. Major Manufacturers of Injectables
Table 5. Major Manufacturers of Feed Additives
Table 6. Global Endoparasiticide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Endoparasiticide Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Endoparasiticide Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Endoparasiticide Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Endoparasiticide Revenue Market Share by Region (2018-2023)
Table 11. Global Endoparasiticide Revenue Market Share by Region (2024-2029)
Table 12. Global Endoparasiticide Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Endoparasiticide Sales by Region (2018-2023) & (K Units)
Table 14. Global Endoparasiticide Sales by Region (2024-2029) & (K Units)
Table 15. Global Endoparasiticide Sales Market Share by Region (2018-2023)
Table 16. Global Endoparasiticide Sales Market Share by Region (2024-2029)
Table 17. Global Endoparasiticide Sales by Manufacturers (2018-2023) & (K Units)
Table 18. Global Endoparasiticide Sales Share by Manufacturers (2018-2023)
Table 19. Global Endoparasiticide Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Endoparasiticide Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Endoparasiticide, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Endoparasiticide Price by Manufacturers 2018-2023 (US$/Unit)
Table 23. Global Endoparasiticide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Endoparasiticide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoparasiticide as of 2022)
Table 25. Global Key Manufacturers of Endoparasiticide, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Endoparasiticide, Product Offered and Application
Table 27. Global Key Manufacturers of Endoparasiticide, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 30. Global Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 31. Global Endoparasiticide Sales Share by Type (2018-2023)
Table 32. Global Endoparasiticide Sales Share by Type (2024-2029)
Table 33. Global Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Endoparasiticide Revenue Share by Type (2018-2023)
Table 36. Global Endoparasiticide Revenue Share by Type (2024-2029)
Table 37. Endoparasiticide Price by Type (2018-2023) & (US$/Unit)
Table 38. Global Endoparasiticide Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 40. Global Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 41. Global Endoparasiticide Sales Share by Application (2018-2023)
Table 42. Global Endoparasiticide Sales Share by Application (2024-2029)
Table 43. Global Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Endoparasiticide Revenue Share by Application (2018-2023)
Table 46. Global Endoparasiticide Revenue Share by Application (2024-2029)
Table 47. Endoparasiticide Price by Application (2018-2023) & (US$/Unit)
Table 48. Global Endoparasiticide Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 50. US & Canada Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 54. US & Canada Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Endoparasiticide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Endoparasiticide Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Endoparasiticide Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Endoparasiticide Sales by Country (2018-2023) & (K Units)
Table 61. US & Canada Endoparasiticide Sales by Country (2024-2029) & (K Units)
Table 62. Europe Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 63. Europe Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 64. Europe Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 67. Europe Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 68. Europe Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Endoparasiticide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Endoparasiticide Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Endoparasiticide Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Endoparasiticide Sales by Country (2018-2023) & (K Units)
Table 74. Europe Endoparasiticide Sales by Country (2024-2029) & (K Units)
Table 75. China Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 76. China Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 77. China Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 80. China Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 81. China Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 84. Asia Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 85. Asia Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 88. Asia Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 89. Asia Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Endoparasiticide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Endoparasiticide Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Endoparasiticide Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Endoparasiticide Sales by Region (2018-2023) & (K Units)
Table 95. Asia Endoparasiticide Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Endoparasiticide Sales by Type (2018-2023) & (K Units)
Table 97. Middle East, Africa and Latin America Endoparasiticide Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Endoparasiticide Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Endoparasiticide Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Endoparasiticide Sales by Application (2018-2023) & (K Units)
Table 101. Middle East, Africa and Latin America Endoparasiticide Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Endoparasiticide Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Endoparasiticide Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Endoparasiticide Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Endoparasiticide Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Endoparasiticide Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Endoparasiticide Sales by Country (2018-2023) & (K Units)
Table 108. Middle East, Africa and Latin America Endoparasiticide Sales by Country (2024-2029) & (K Units)
Table 109. Boehringer Ingelheim Company Information
Table 110. Boehringer Ingelheim Description and Major Businesses
Table 111. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Boehringer Ingelheim Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Boehringer Ingelheim Recent Developments
Table 114. Elanco Company Information
Table 115. Elanco Description and Major Businesses
Table 116. Elanco Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Elanco Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Elanco Recent Developments
Table 119. Zoetis Company Information
Table 120. Zoetis Description and Major Businesses
Table 121. Zoetis Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Zoetis Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Zoetis Recent Developments
Table 124. Merck Company Information
Table 125. Merck Description and Major Businesses
Table 126. Merck Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Merck Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Merck Recent Developments
Table 129. Virbac Company Information
Table 130. Virbac Description and Major Businesses
Table 131. Virbac Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Virbac Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Virbac Recent Developments
Table 134. Novartis AG Company Information
Table 135. Novartis AG Description and Major Businesses
Table 136. Novartis AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Novartis AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Novartis AG Recent Developments
Table 139. Ceva Sante Animlae Company Information
Table 140. Ceva Sante Animlae Description and Major Businesses
Table 141. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Ceva Sante Animlae Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Ceva Sante Animlae Recent Developments
Table 144. Bayer AG Company Information
Table 145. Bayer AG Description and Major Businesses
Table 146. Bayer AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Bayer AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Bayer AG Recent Developments
Table 149. Eli Lilly Company Information
Table 150. Eli Lilly Description and Major Businesses
Table 151. Eli Lilly Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Eli Lilly Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Eli Lilly Recent Developments
Table 154. Vetoquinol Company Information
Table 155. Vetoquinol Description and Major Businesses
Table 156. Vetoquinol Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Vetoquinol Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Vetoquinol Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Endoparasiticide Distributors List
Table 162. Endoparasiticide Customers List
Table 163. Endoparasiticide Market Trends
Table 164. Endoparasiticide Market Drivers
Table 165. Endoparasiticide Market Challenges
Table 166. Endoparasiticide Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Endoparasiticide Product Picture
Figure 2. Global Endoparasiticide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Endoparasiticide Market Share by Type in 2022 & 2029
Figure 4. Ear Tags Product Picture
Figure 5. Tablets Product Picture
Figure 6. Injectables Product Picture
Figure 7. Feed Additives Product Picture
Figure 8. Global Endoparasiticide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Endoparasiticide Market Share by Application in 2022 & 2029
Figure 10. Veterinary Hospitals or Clinics
Figure 11. Animal Farms
Figure 12. Home Care Settings
Figure 13. Endoparasiticide Report Years Considered
Figure 14. Global Endoparasiticide Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Endoparasiticide Revenue 2018-2029 (US$ Million)
Figure 16. Global Endoparasiticide Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Endoparasiticide Revenue Market Share by Region (2018-2029)
Figure 18. Global Endoparasiticide Sales 2018-2029 ((K Units)
Figure 19. Global Endoparasiticide Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 25. China Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Endoparasiticide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Endoparasiticide in the World: Market Share by Endoparasiticide Revenue in 2022
Figure 32. Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 34. Global Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 35. Global Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 36. Global Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Endoparasiticide Revenue Share by Country (2018-2029)
Figure 42. US & Canada Endoparasiticide Sales Share by Country (2018-2029)
Figure 43. U.S. Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 46. Europe Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 47. Europe Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 48. Europe Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 49. Europe Endoparasiticide Revenue Share by Country (2018-2029)
Figure 50. Europe Endoparasiticide Sales Share by Country (2018-2029)
Figure 51. Germany Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 52. France Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 56. China Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 57. China Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 58. China Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 59. China Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 60. Asia Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 61. Asia Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 62. Asia Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 63. Asia Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 64. Asia Endoparasiticide Revenue Share by Region (2018-2029)
Figure 65. Asia Endoparasiticide Sales Share by Region (2018-2029)
Figure 66. Japan Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 70. India Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Endoparasiticide Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Endoparasiticide Sales Share by Country (2018-2029)
Figure 77. Brazil Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 82. Endoparasiticide Value Chain
Figure 83. Endoparasiticide Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Figure 1. Endoparasiticide Product Picture
Figure 2. Global Endoparasiticide Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Endoparasiticide Market Share by Type in 2022 & 2029
Figure 4. Ear Tags Product Picture
Figure 5. Tablets Product Picture
Figure 6. Injectables Product Picture
Figure 7. Feed Additives Product Picture
Figure 8. Global Endoparasiticide Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Endoparasiticide Market Share by Application in 2022 & 2029
Figure 10. Veterinary Hospitals or Clinics
Figure 11. Animal Farms
Figure 12. Home Care Settings
Figure 13. Endoparasiticide Report Years Considered
Figure 14. Global Endoparasiticide Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Endoparasiticide Revenue 2018-2029 (US$ Million)
Figure 16. Global Endoparasiticide Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Endoparasiticide Revenue Market Share by Region (2018-2029)
Figure 18. Global Endoparasiticide Sales 2018-2029 ((K Units)
Figure 19. Global Endoparasiticide Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 25. China Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Endoparasiticide Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Endoparasiticide Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Endoparasiticide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Endoparasiticide in the World: Market Share by Endoparasiticide Revenue in 2022
Figure 32. Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 34. Global Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 35. Global Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 36. Global Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Endoparasiticide Revenue Share by Country (2018-2029)
Figure 42. US & Canada Endoparasiticide Sales Share by Country (2018-2029)
Figure 43. U.S. Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 46. Europe Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 47. Europe Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 48. Europe Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 49. Europe Endoparasiticide Revenue Share by Country (2018-2029)
Figure 50. Europe Endoparasiticide Sales Share by Country (2018-2029)
Figure 51. Germany Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 52. France Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 56. China Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 57. China Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 58. China Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 59. China Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 60. Asia Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 61. Asia Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 62. Asia Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 63. Asia Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 64. Asia Endoparasiticide Revenue Share by Region (2018-2029)
Figure 65. Asia Endoparasiticide Sales Share by Region (2018-2029)
Figure 66. Japan Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 70. India Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Endoparasiticide Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Endoparasiticide Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Endoparasiticide Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Endoparasiticide Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Endoparasiticide Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Endoparasiticide Sales Share by Country (2018-2029)
Figure 77. Brazil Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Endoparasiticide Revenue (2018-2029) & (US$ Million)
Figure 82. Endoparasiticide Value Chain
Figure 83. Endoparasiticide Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
